Back to search

Article

CAR-T-Cell Therapy: Present Progress and Future strategies

2022-02-28

Abstract excerpt

Chimeric antigen receptor (CAR) T-cell therapy is a type of immunotherapy that uses the patient's immune system. It creates cancer-killing T cells through genetic modification that targets tumor antigens. CAR consists of three fundamental units, the extracellular, transmembrane, and intracellular domains. CARs are rapidly evolving with progress in the field of immunotherapy starting from first-generation CARs to n...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
685256dc-2eea-51c2-9b28-b2f526c6b386
DOI
10.15419/bmrat.v9i2.726
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CAR-T-Cell Therapy: Present Progress and Future strategiesDOI 10.15419/bmrat.v9i2.726
Chimeric Antigen Receptor (CAR) T Cells: A Detailed Review of Origins, Engineering, and Therapeutic ImpactSemantic proximity
CAR T Cell Therapy: A Versatile Living DrugSemantic proximity
CAR T-cell Therapy: A New Era in Cancer ImmunotherapySemantic proximity
Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T CellsSemantic proximity
CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities.Semantic proximity
CAR‐T‐cell products in solid tumors: Progress, challenges, and strategiesSemantic proximity
Next-Generation Chimeric Antigen Receptor T-cellsSemantic proximity
Chimeric Antigen Receptor T-Cell Therapy: What We Expect SoonSemantic proximity
Chimeric antigen receptor-modified T cells strike backSemantic proximity
Chimeric Antigen Receptor‐T Cell TherapySemantic proximity
Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cellsSemantic proximity
Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignanciesSemantic proximity
Select a neighboring publication to make it the new centre.